- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Amanda L. Hayes-Kibreab
Event 9 results
Webinar
March 17, 2021
Issues Facing California Healthcare Providers: Class Action Litigation in the Wake of the Covid-19 Pandemic and Developing Legislation
Webinar
January 26, 2021
An Update on Payer Specialty Pharmacy Policies, How the Industry is Responding to Them, and What is at Stake for Hospitals
Webinar
January 12, 2021
The New Frontier in Managed Care: An Overview of the Newly Passed Federal Surprise Billing Legislation
Webinar
July 10, 2020
Managing Provider Risk: Return-to-Work for Non-Essential Employees and the Resumption of Elective Procedures
Webinar
Webinar
May 22, 2020
Part Two: COVID-19: How to Get Paid by Commercial, Managed Medicare and Managed Medicaid Payers in the Months to Come
Webinar
Webinar
January 22, 2020
A Review of the Practical and Legal Challenges Posed by CMS’s New Hospital Price Transparency Rule